Amid China's rapidly aging population, Dahao Medical emerges as a key player in rehabilitation assistive devices, manufacturing electric wheelchairs, transfer chairs and hospital beds. Benefiting from strong government policy support including financial incentives and market access reforms, the company drives industry innovation while addressing growing demand for quality mobility solutions. Through continuous R&D investment and global expansion, Dahao exemplifies how Chinese enterprises are transforming rehabilitation care in response to demographic shifts.

Dahao Medical, a leading Chinese rehabilitation equipment manufacturer, is addressing global aging challenges with innovative electric wheelchairs, hospital beds and transfer chairs. Their intelligent products combine German engineering with user-friendly features like voice control and anti-tip systems, helping elderly and mobility-impaired users regain independence.

On December 12, 2024, the National Health Commission and other five departments jointly issued the Guiding Opinions on Promoting the High-Quality Development of Healthcare Integration Services, proposing to support the inclusion of qualified healthcare integration institutions into the scope of health insurance designated points and the inclusion of therapeutic rehabilitation aids into the scope of health insurance payment.